+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 3Months +
All Genders
ID05588167

Creating a Comprehensive Genomic and Phenotypic Database to Understand Niemann-Pick Disease, Type C

Led by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Updated on 2026-10-15

100

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Niemann-Pick type C NPC disease is a rare, progressive neurodegenerative disorder affecting the brain, liver, spleen, and other body parts. Symptoms vary widely among people and may include seizures, difficulty moving or talking, or dementia. Researchers aim to better understand why NPC affects individuals differently by studying clinical and genomic data in this natural history observational study. Participants diagnosed with NPC will provide a one-time blood sample for DNA analysis. Their medical records will be reviewed to collect detailed information about diagnosis, symptoms, duration of symptoms, and other health data such as age, sex, race, height, weight, medications, and test results. The study will establish the largest genomic and phenotypic database to support future NPC research. Throughout the study, the research team will communicate with participants to explain procedures and answer questions. The primary outcomes include collecting clinical data and genomic markers over two years, including whole genome analysis. Participants may receive compensation up to 190. The study is observational and does not include treatment interventions.

CONDITIONS

Brief Title

Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C

Research Team

D

Desiree A Labor, C.R.N.P.

F

Forbes D Porter, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here